abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2017年4月17日

作者:
Grant Schulte, AP (USA)

USA: Fresenius says Nebraska should not have been able to obtain company's drug for death penalty use

Company: Nebraska shouldn’t have gotten death penalty drug, 13 April 2017

A German pharmaceutical manufacturer whose drugs ended up in Nebraska’s lethal injection supply never intended for state officials to obtain them and tried unsuccessfully to get the corrections department to return them, a company spokesman said Thursday.  Nebraska’s corrections department was only able to buy potassium chloride in 2015 because one of its U.S. distributors made a mistake, said Fresenius Kabi spokesman Matt Kuhn.  His comments came after The Associated Press asked whether company officials were aware that the Nebraska Department of Correctional Services had bought their product for use as a lethal injection drug... 

While the company takes no formal position on capital punishment, it requires distributors to sign an agreement promising not sell certain drugs to state corrections departments.  “Our products are developed and approved solely for patient care, and we expressly restrict the sale of our products for use in lethal injection,” he said.

The American Civil Liberties Union of Nebraska, a leading critic of capital punishment, called on lawmakers to reject the push for secrecy and launch an investigation.  “These shocking allegations are just the latest illustration of how Nebraska’s death penalty is broken beyond repair,” said Danielle Conrad, the group’s executive director. The company’s statement “underscores the need to honor Nebraska’s strong tradition of open government and the need to ensure transparency in the death penalty process.”

Death penalty supporters said companies shouldn’t dictate how their products are used once they’re sold and blamed anti-death penalty activists for pressuring companies to stop selling drugs with legitimate medical purposes...

Robert Dunham, executive director of the Death Penalty Information Center,...said many pharmaceutical companies are worried about negative publicity and economic consequences in addition to moral concerns about the death penalty. [also refers to Mylan, Naari]

隱私資訊

本網站使用 cookie 和其他網絡存儲技術。您可以在下方設置您的隱私選項。您所作的更改將立即生效。

有關我們使用網絡儲存技術的更多資訊,請參閱我們的 數據使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析cookie

ON
OFF

您瀏覽本網頁時我們將以Google Analytics收集信息。接受此cookie將有助我們理解您的瀏覽資訊,並協助我們改善呈現資訊的方法。所有分析資訊都以匿名方式收集,我們並不能用相關資訊得到您的個人信息。谷歌在所有主要瀏覽器中都提供退出Google Analytics的添加應用程式。

市場營銷cookies

ON
OFF

我們從第三方網站獲得企業責任資訊,當中包括社交媒體和搜尋引擎。這些cookie協助我們理解相關瀏覽數據。

您在此網站上的隱私選項

本網站使用 cookie 和其他網絡儲存技術來增強您在必要核心功能之外的體驗。